Novo Nordisk at PepTalk 2027
Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website
Novo Nordisk brings 5 presentations to PepTalk 2027 in Carlsbad. Its program centers on the honest impact of AI on biologic drug discovery and on where peptide therapeutics are heading. The peptide sessions run from constrained scaffolds and AI-designed clinical candidates to the design of better peptide delivery systems.
| Organization | PepTalk 2027 Attendance |
|---|---|
Novo Nordisk Bagsværd, Denmark | |
Danish pharmaceutical company known for insulin and GLP-1 peptide medicines for diabetes and obesity, with protein and peptide discovery research. | Chair Tue Jan 19 4:20pm–4:25pm Panel Tue Jan 19 4:55pm–5:25pm AI's Real Impact on Biologic Drug Discovery: The Honest Scorecard Predictive and AI-driven protein science Panel Tue Jan 19 5:45pm–6:05pm Panel Wed Jan 20 1:20pm–2:15pm Peptides at the Inflection Point: From Constrained Scaffolds to AI-Designed Clinical Candidates—Where is Peptide Therapeutics Headed? Peptide discovery and developmentPredictive and AI-driven protein science Talk Thu Jan 21 3:20pm–3:45pm |
Instantly find 20 buyers from Novo Nordisk
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by PepTalk or its organizers. Submit a correction